A Novel Toll-Like Receptor 2 Agonist Protects Mice in a Prophylactic Treatment Model Against Challenge With Bacillus anthracis.
Chiang CY, Lane DJ, Zou Y, Hoffman T, Pan J, Hampton J, Maginnis J, Nayak BP, D'Oro U, Valiante N, Miller AT, Cooke M, Wu T, Bavari S, Panchal RG.
Chiang CY, et al. Among authors: hoffman t.
Front Microbiol. 2022 Mar 14;13:803041. doi: 10.3389/fmicb.2022.803041. eCollection 2022.
Front Microbiol. 2022.
PMID: 35369443
Free PMC article.